Drugs for Rare Diseases May Get Faster FDA Approvals

Drugs for Rare Diseases May Get Faster FDA Approvals

Senator Kay Hagan's plan would allow agency approvals based on the second of three phases of clinical trials, when data can’t be “ethically, feasibly or practicably generated,” according to a draft. Photo: Alex Wong/Getty Images